These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31811328)

  • 1. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
    Klose S; Pflock R; König IR; Linder R; Schwaninger M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.
    Lerman TT; Sagi M; Shafir Y; Sheena L; Cohen E; Goldberg E; Krause I
    Br J Clin Pharmacol; 2021 Jul; 87(7):2902-2906. PubMed ID: 33332642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metamizole (Dipyrone) and the Liver: A Review of the Literature.
    Lutz M
    J Clin Pharmacol; 2019 Nov; 59(11):1433-1442. PubMed ID: 31433499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
    Rudin D; Spoendlin J; Cismaru AL; Liakoni E; Bonadies N; Amstutz U; Meier CR; Krähenbühl S; Haschke M
    Eur J Intern Med; 2019 Oct; 68():36-43. PubMed ID: 31383393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Agranulocytosis Associated with Metamizole Treatment.
    Kılıç Ö; İşeri Nepesov M; Ulukapı HB; Özdemir ZC; Bör Ö; Dinleyici EÇ
    Paediatr Drugs; 2021 Jan; 23(1):105-110. PubMed ID: 33247375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
    Allgaier R; Kandulski A; Gülow K; Maier L; Müller M; Tews HC
    Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
    Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
    Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
    Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case Report - Metamizole-Induced Agranulocytosis].
    Gonnert FA; Meißner W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukopenia with unclear fever].
    Mayer S; Kündiger T; Schrader H
    Internist (Berl); 2017 Jul; 58(7):740-744. PubMed ID: 28265684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyrone-induced granulocytopenia: a case for awareness.
    Garcia S; Canionero M; Lopes G
    Pharmacotherapy; 2006 Mar; 26(3):440-2. PubMed ID: 16503727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.
    Radulovic I; Dogan B; Dohna-Schwake C; Schündeln MM; Siffert W; Möhlendick B
    Pharmacogenet Genomics; 2021 Aug; 31(6):140-143. PubMed ID: 33675325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal Outcome of Agranulocytosis after Re-Exposure to Metamizole and Cefepime-Induced Encephalopathy].
    Skaistys A; Rätz Bravo AE; Leuppi-Taegtmeyer A; Zysset Y
    Praxis (Bern 1994); 2019 Aug; 108(10):693-697. PubMed ID: 31387493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.